RBM47 and neoplasm: Further analysis of The Cancer Genome Atlas (TCGA) database revealed a stepwise reduction of RBM47 expression with advancing tumor stage (Figure 9F), which was independently predictive of both overall and progression-free survival (Figure 9G).